NEWS

Activity Summary

There are seven interns from all over the world. They are going to sharing their experience and special project on 8/15. Join us and learn what did they done in Cancerfree 5th internship 2024.

Introduction

Over the course of a two-month summer internship encompassing business development, software engineering, research, marketing, and design, each intern eagerly anticipates the challenges ahead. From initial unfamiliarity with the workplace to overcoming diverse challenges, interns are poised to absorb and excel. This opportunity allows us to collectively assess our capabilities and embrace a brighter future!
 

Theme Story

A 9-week summer internship program, this journey is filled with challenges, growth, and teamwork. Each participant brings their own experience, combining strength, intellect, and agility. With two months of intense team battles and workplace experience, this 2024 summer challenge elevates the interns to an entirely new level.

Time & Location

• Time：8/15 13:00~17:00
• Locate： t-Hub (No. 335 號, Ruiguang Rd, Neihu District, Taipei City, 114)
• Languege: Chinese
• Link: https://www.accupass.com/event/2407180906411493447602

Schedule

• 12:30-13:00 Preparing/open to join the meeting room
• 13:00 Demo Day starts 13:00-13:15 Welcome speech
• 13:15-13:40 Guest speaker : Jessie Chan
• 13:45-15:25 Intern project sharing
• 15:25-15:35 Q&A
• 15:35-15:55 Closing remark
• 15:55~16:30 Networking

About CancerFree Biotech Ltd.

With a focus on the analysis of circulating tumor cells (CTCs). CancerFree Biotech is committed to developing a more competitive, personalized anticancer drug testing service. Current cancer treatment is based on standard treatment protocols and physician experience, but individual differences make treatment methods work differently for each patient. Through our services, doctors will know the actual effect of drugs on patients' cancer cells, and can further tailor treatment to patients' conditions, reducing the risk of patients trying drugs on themselves and reducing the risk and cost of potentially ineffective drugs.